What’s your opinion on the recent court ruling about FDA’s role in advising on ivermectin use?

In a recent landmark ruling, a federal appeals court in New Orleans ruled in favor of doctors advocating for the use of ivermectin in treating COVID-19. The court agreed that the Food and Drug Administration (FDA) overstepped its legal boundaries in its attempt to dismiss a lawsuit brought by three doctors regarding the use of ivermectin. The court also critiqued the FDA's misleading messaging which failed to inform the public of a human version of ivermectin. This case highlights the limits of FDA's authority, underscoring that it can inform but not advise.